Emergence of extended-spectrum β-lactamase (ESBL) CTX-M-8 in Germany

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 2, 2014, Pages 562-564

  Eller, Christoph ^a   Leistner, Rasmus ^b   Guerra, Beatriz ^c   Fischer, Jennie ^c   Wendt, Constanze ^d   Rabsch, Wolfgang ^a   Werner, Guido ^a   Pfeifer, Yvonne ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^d Labor Limbach   (Germany)

Author keywords

Antimicrobial resistance; Community acquired; Escherichia coli; Food; Salmonella

Indexed keywords

CEFOTAXIME; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENE SEQUENCE; GERMANY; HUMAN; INTESTINE; LETTER; MEAT; NONHUMAN; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; REPLICON; SALMONELLA ENTERICA; SALMONELLOSIS; SEROTYPE; SPECIES; URINARY TRACT INFECTION;

ANTIMICROBIAL RESISTANCE; COMMUNITY ACQUIRED; ESCHERICHIA COLI; FOOD; SALMONELLA;

BACTERIAL PROTEINS; BETA-LACTAMASES; ESCHERICHIA COLI INFECTIONS; GERMANY; HUMANS;

EID: 84892474599     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt387     Document Type: Letter

References (13)

1. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
2. Eller C, Simon S, Miller T et al. Presence of β-lactamases in extendedspectrum- cephalosporin-resistant Salmonella enterica of 30 different serovars in Germany 2005-11. J Antimicrob Chemother 2013; 68:1978-81.
3. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-8.
4. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
5. Poirel L, Kämpfer P, Nordmann P. Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob Agents Chemother 2002; 46: 4038-40.
6. García-Fernández A, Chiaretto G, Bertini A et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin. J Antimicrob Chemother 2008; 61: 1229-33.
7. Rodríguez I, Barownick W, Helmuth R et al. Extended-spectrum β-lactamases and AmpC β-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07. J Antimicrob Chemother 2009; 64: 301-9.
8. Bonnet R, Sampaio JL, Labia R et al. AnovelCTX-M β-lactamase(CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 2000; 44: 1936-42.
9. Garcia-Fulgueiras V, Bado I, Mota MI et al. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J Antimicrob Chemother 2011; 66:1725-9.
10. Lewis JS, Herrera M, Wickes B et al. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007; 51: 4015-21.
11. Jouini A, Vinue L, Slama KB et al. Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 2007; 60: 1137-41.
12. Peirano G, Laupl and KB, Gregson DB et al. Colonizationof returning travelers with CTX-M-producing Escherichia coli. J Travel Med 2011; 18: 299-303.
13. Vinue L, Saenz Y, Martinez S et al. Prevalence and diversity of extended-spectrum β-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009; 15: 954-7.